Operating income before deduction of amortization: anbio.com (NNNN)
Intense pricing competition in the diagnostics sector is forcing Anbio Biotechnology to scale budget production. This EBITDA chart visualizes these market fluctuations, with the indicator currently standing at 6.54. While geopolitical barriers are currently hindering equipment exports, the implementation of autonomous robotic biomaterial analysis systems is significantly accelerating the interpretation of medical tests.
Summary analytical data breakdowns for Anbio (NNNN)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
Total Debt to Capital Anbio Biotechnology|NNNN - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Anbio Biotechnology Ltd|NNNN - Company Aggregate Debts|Debt to Book Capitalization Ratio Anbio Biotechnology|NNNN - Company Long-Term Debts|Short-Term Debt Volume Anbio Biotechnology|Immediate Liquidity anbio.com
- company profitability and valuation multiples indicators:
NNNN - Net Income|Expected Net Income Anbio Biotechnology|NNNN - P/E Multiple|Future Price to Earnings anbio.com|NNNN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Anbio Biotechnology|NNNN - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Anbio Biotechnology|NNNN - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months anbio.com|NNNN - Earnings growth in current year|Expected net earnings per share growth next year Anbio Biotechnology
Summary company analytics:Anbio Corp (NNNN)
Analyzing EBITDA is critical for constructing a defensive portfolio, as it measures the actual cash flow from core business operations. In the case of Anbio Biotechnology (NNNN), the volume of operating cash results reflects the efficiency of mass sales of diagnostic systems and reagents to clinics, where a stable trend line confirms the company's fundamental resilience to market shocks.
Who Anbio Biotechnology competes with
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Nordion (SHC) - Operating income before deduction of amortization|Operating profit EBITDA QDEL|Operating profit EBITDA opko.com (OPK)|Profit before payment of interest, taxes and amortization CareDx Inc CDNA|MRVI: Operating profit before amortization|Fulgent Corp - Operating profit EBITDA|LAB: Profit before payment of interest, taxes and amortization|CTKB: Operating profit EBITDA|OSUR - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Exagen Inc|Profit before interest, taxes and amortization MDxHealth S.A. MDXH|Operating profit before deduction of amortization LUCD (Lucid Diagnostics Inc)|PRE (prenetics.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA IMDX (Insight Molecular Diagnostics Inc)|Trinity Biotech PLC - Profit before payment of interest, taxes and amortization|ProPhase Labs - Operating profit EBITDA|Operating income before deduction of amortization Ainos Inc AIMD|Co-Diagnostics Corp (CODX) - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Heart Test Labs (HSCS)|Operating profit before deduction of amortization BMRA|CDIO (Cardio Diagnostics Holdings, Inc.) - Company profit before taxes, interest and amortization|Operating profit EBITDA ONCO|VRAX - Profit before interest, taxes and amortization|Operating profit EBITDA BJDX (Bluejay)|AWH - Operating profit before deduction of amortization|Accelerate Diagnostics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization CNTG (Centogene)|enzo.com (ENZ) - Profit before payment of interest, taxes and amortization|Operating profit before amortization FRES|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Profit before interest, taxes and amortization 23andMe Inc ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
